Quick Answer
Apimeds Pharmaceuticals US, Inc. reported Common Stock Shares Outstanding of 7.90 million shares for the year ending 2024.
- Apimeds Pharmaceuticals US, Inc. showed an increase of +0.0% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Apimeds Pharmaceuticals US, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2024: 7.90 million shares | Fiscal year 2023: 7.90 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: